RMS

1,668.5

-0.51%↓

BMW

77.7

+1.22%↑

VOW

88.45

+0.63%↑

VOW3

86.56

+0.32%↑

KER

251

+2.7%↑

RMS

1,668.5

-0.51%↓

BMW

77.7

+1.22%↑

VOW

88.45

+0.63%↑

VOW3

86.56

+0.32%↑

KER

251

+2.7%↑

RMS

1,668.5

-0.51%↓

BMW

77.7

+1.22%↑

VOW

88.45

+0.63%↑

VOW3

86.56

+0.32%↑

KER

251

+2.7%↑

RMS

1,668.5

-0.51%↓

BMW

77.7

+1.22%↑

VOW

88.45

+0.63%↑

VOW3

86.56

+0.32%↑

KER

251

+2.7%↑

RMS

1,668.5

-0.51%↓

BMW

77.7

+1.22%↑

VOW

88.45

+0.63%↑

VOW3

86.56

+0.32%↑

KER

251

+2.7%↑

Search

Evonik Industries AG

Atvērts

SektorsCikliskās patēriņa

14.65 3.9

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

13.65

Max

14.65

Galvenie mērījumi

By Trading Economics

Ienākumi

174M

68M

Pārdošana

12M

3.4B

P/E

Sektora vidējais

25.246

33.36

EPS

0.15

Dividenžu ienesīgums

6.96

Peļņas marža

1.998

Darbinieki

28,650

EBITDA

-39M

367M

Rekomendācijas

By TipRanks

Rekomendācijas

Neitrāls

Prognoze 12 mēnešiem

+7.6% upside

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

6.96%

3.17%

Nākamie ieņēmumi

2026. g. 8. maijs

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

317M

6.7B

Iepriekšējā atvēršanas cena

10.75

Iepriekšējā slēgšanas cena

14.65

Ziņu noskaņojums

By Acuity

40%

60%

108 / 338 Rangs Consumer cyclical

Tehniskais rādītājs

By Trading Central

Pārliecība

Weak Bullish Evidence

Evonik Industries AG Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 23. marts 23:47 UTC

Iegādes, apvienošanās, pārņemšana

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

2026. g. 23. marts 22:55 UTC

Iegādes, apvienošanās, pārņemšana

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

2026. g. 23. marts 21:51 UTC

Iegādes, apvienošanās, pārņemšana

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

2026. g. 23. marts 23:59 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 23. marts 23:59 UTC

Tirgus saruna

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

2026. g. 23. marts 23:50 UTC

Tirgus saruna

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

2026. g. 23. marts 23:37 UTC

Tirgus saruna

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

2026. g. 23. marts 22:42 UTC

Tirgus saruna
Galvenie ziņu notikumi

Global Equities Roundup: Market Talk

2026. g. 23. marts 22:42 UTC

Tirgus saruna
Galvenie ziņu notikumi

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

2026. g. 23. marts 22:40 UTC

Iegādes, apvienošanās, pārņemšana

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

2026. g. 23. marts 22:23 UTC

Tirgus saruna

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

2026. g. 23. marts 22:22 UTC

Iegādes, apvienošanās, pārņemšana

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

2026. g. 23. marts 22:21 UTC

Iegādes, apvienošanās, pārņemšana

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

2026. g. 23. marts 22:21 UTC

Iegādes, apvienošanās, pārņemšana

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

2026. g. 23. marts 22:20 UTC

Iegādes, apvienošanās, pārņemšana

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

2026. g. 23. marts 22:20 UTC

Iegādes, apvienošanās, pārņemšana

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

2026. g. 23. marts 22:19 UTC

Iegādes, apvienošanās, pārņemšana

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

2026. g. 23. marts 22:19 UTC

Iegādes, apvienošanās, pārņemšana

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

2026. g. 23. marts 22:18 UTC

Iegādes, apvienošanās, pārņemšana

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

2026. g. 23. marts 22:15 UTC

Iegādes, apvienošanās, pārņemšana

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

2026. g. 23. marts 22:08 UTC

Tirgus saruna

Ebos Needs to Reset Its Gearing Targets -- Market Talk

2026. g. 23. marts 21:42 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 23. marts 21:42 UTC

Tirgus saruna

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

2026. g. 23. marts 21:32 UTC

Peļņas

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

2026. g. 23. marts 21:32 UTC

Peļņas

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

2026. g. 23. marts 21:32 UTC

Peļņas

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

2026. g. 23. marts 21:10 UTC

Galvenie ziņu notikumi

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

2026. g. 23. marts 20:50 UTC

Tirgus saruna

Tech, Media & Telecom Roundup: Market Talk

2026. g. 23. marts 20:50 UTC

Tirgus saruna

Health Care Roundup: Market Talk

2026. g. 23. marts 20:50 UTC

Tirgus saruna
Peļņas
Galvenie ziņu notikumi

Basic Materials Roundup: Market Talk

Salīdzinājums

Cenas izmaiņa

Evonik Industries AG Prognoze

Cenas mērķis

By TipRanks

7.6% augšup

Prognoze 12 mēnešiem

Vidējais 15 EUR  7.6%

Augstākais 20.4 EUR

Zemākais 12.2 EUR

Pamatojoties uz 12 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Evonik Industries AG — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

12 ratings

2

Pirkt

7

Turēt

3

Pārdot

Tehniskais rādītājs

By Trading Central

19.83 / 20Atbalsts un pretestība

Īstermiņā

Weak Bullish Evidence

Vidējā termiņā

Strong Bullish Evidence

Ilgtermiņā

Bullish Evidence

Noskaņojums

By Acuity

108 / 338 Rangs Cikliskās patēriņa

Ziņu noskaņojums

Liecība "Buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Virs vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Evonik Industries AG

Evonik Industries AG produces specialty chemicals in the Asia-Pacific, Europe, the Middle East, Africa, Central and South America, and North America. It operates through Specialty Additives, Nutrition & Care, Smart Materials, Performance Materials, and Technology & Infrastructure segments. The Specialty Additives segment provides additives for polyurethane; additives, matting agents, fumed silicas, and specialty resins for paints, coatings, and printing inks; isophorone and epoxy curing agents for coatings, adhesives, and composites; and pour-point depressants, and viscosity index improvers for coatings for oil and other lubricants for construction machinery and automotive sector. The Nutrition & Care segment offers D-/l-methionine and lysine for animal nutrition industry; amino acids and peptides; pharmaceutical active ingredients; and biocompatible and bioresorbable materials for orthopedic and medical applications; and system solutions for the cosmetics and detergent industries. The Smart Materials segment provides inorganic materials, including fumed and precipitated silicas and silanes; peroxides for paper and textile industries; specialty catalysts for synthesis and alkoxides; polymers products, such as polymide 12, polymer foam, specialty polybutadiene and polyester, alkoxides, and membranes. The Performance Materials offers C4 derivatives consisting of butadiene, MTBE, butene-1, isononanol, and DINP for use in automotive industry; and superabsorbent products for diapers and hygiene products. The Technology & Infrastructure segment provides energy management, integrated plant support and maintenance, process safety and engineering, pipelines, transport management, logistics safety, digital solutions for chemical production, and strategic site development services. The company was founded in 1873 and is headquartered in Essen, Germany.
help-icon Live chat